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Abstract
Gamma oscillations are a prominent feature of hippocampal network activity, but their functional
role remains debated, ranging from mere epiphenomenon to crucial for information processing.
Similarly, persistent gamma oscillations sometimes appear prior to epileptic discharges in patients
with mesial temporal sclerosis. However, the significance of this activity in hippocampal
excitotoxicity is unclear. We assessed the relationship between kainic acid (KA)-induced gamma
oscillations and excitotoxicity in genetically-engineered mice in which N-methyl-D-aspartic acid
(NMDA) receptor deletion was confined to CA3 pyramidal cells. Mutants showed reduced CA3
pyramidal cell firing and augmented sharp wave-ripple activity, resulting in higher susceptibility
to KA-induced seizures, and leading to strikingly selective neurodegeneration in the CA1 subfield.
Interestingly, the KA-induced gamma-aminobutyric acid (GABA) level increases and persistent
30-50 Hz gamma oscillations observed in control mice prior to the first seizure discharge was
abolished in the mutants. Consequently, on subsequent days, mutants manifested prolonged
epileptiform activity and massive neurodegeneration of CA1 cells, including local GABAergic
neurons. Remarkably, pretreatment with the potassium channel blocker α-dendrotoxin (DTX)
increased GABA levels, restored gamma oscillations, and prevented CA1 degeneration in the
mutants. These results demonstrate that emergence of low frequency gamma oscillations predicts
increased resistance to KA-induced excitotoxicity, raising the possibility that gamma oscillations
may have potential prognostic value for the treatment of epilepsy.
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Introduction
Gamma oscillations in cortical structures, defined as synchronous rhythmic oscillatory
activity from 30 to 100 Hz, are believed to play a role in neural communication and
information processing (Singer & Gray, 1995; Buzsáki & Draguhn, 2004). While these
physiological gamma oscillations are transiently induced by sensory stimulations (for
hundreds of ms to 1 sec), persistent gamma oscillations lasting many sec or even min (Traub
et al., 1999) have also been observed in human epileptic patients (Uhlhaas & Singer, 2006;
Hughes, 2008); indeed, these gamma oscillations are often observed before or coincident
with the onset of seizure discharges (Allen et al., 1992; Fisher et al., 1992; Alarcon et al.,
1995; Medvedev, 2001; Jirsch et al., 2006). An increase in high-frequency (60-100 Hz)
oscillations prior to the onset of neocortical seizures sometimes anticipates subsequent
epileptic seizures (Worrell et al., 2004). In contrast, low gamma oscillations are typically
associated with a favorable prognosis after resective surgery (Lee et al., 2000; Park et al.,
2002). Therefore, their significance in excitotoxic insults has remained elusive.
Systemic and intrahippocampal injection of kainic acid (KA) in rodents induces
epileptiform-like seizures and massive neurodegeneration, which has been used as an animal
model of temporal lobe epilepsy (Schwob et al., 1980; Nadler, 1981; Ben-Ari, 1985; Sperk,
1994). Interestingly, KA administration also induces complex epileptiform EEG patterns,
including gamma oscillations, which precede the ictal-like seizure discharges and
generalized behavioral seizures (Bragin et al., 1999; Medvedev et al., 2000; Khazipov &
Holmes, 2003; Sakatani et al., 2008). KA-induced oscillations in the CA3 subfield of the
hippocampus are completely blocked by bicuculline, a γ-aminobutyric acid (GABA)A
receptor antagonist, but they are largely maintained in the presence of the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists in slice
preparations (Fisahn et al., 2004), as well as in vivo preparations (Khazipov & Holmes,
2003). The strong reliance of gamma oscillations on GABAA receptors suggests these
oscillations arise from a network of mutually connected GABAergic neurons (Whittington et
al., 1995; Bartos et al., 2007; Mann & Paulsen, 2007). KA administration also produces
neuronal degeneration, mainly in the limbic area of the brain, where hippocampal pyramidal
cells are highly vulnerable (Schwob et al., 1980; Sperk, 1994). However, the relationship
between the gamma oscillations that precede seizures and KA-induced excitotoxicity has, to
date, not been explored.
In the current study, we initially assessed KA-induced seizure susceptibility in mice where
NR1, the essential subunit of N-methyl-D-aspartic acid (NMDA) receptors, was selectively
ablated from CA3 pyramidal cells [CA3-NR1 knockout (KO) mice, hereafter referred to as
mutants] (Nakazawa et al., 2002). We found that compared to control mice, the mutants
were more susceptible to KA-induced seizures and massive neurodegeneration that was
confined to area CA1 of the hippocampus. Interestingly, in mutants, persistent 30-50 Hz
gamma oscillations prior to seizure discharges were not detectable in area CA1. The
relationship between the gamma oscillations that precede seizures and KA-induced
excitotoxicity is discussed.
Materials and Methods
All experimental procedures were carried out in accordance with the National Research
Council (NRC)’s Guide for the Care and Use of Laboratory Animals, and were approved by
the National Institute of Mental Health (NIMH) Animal Care and Use Committee.
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Animals
Subjects were naïve males of CA3-NR1 KO (Cre +/−; NR1 flox/flox) mutant mice and their
three control littermates; floxed-NR1 (fNR1; Cre −/−; NR1 flox/flox), hemizygous
G32-4(CA3)-Cre (Cre +/−; NR1 +/+), and wild-type mice from a C57BL/6NTac (B6)
background. All mice were between the ages of 18 to 26 wk and were obtained by the same
breeding method as previously described (Nakazawa et al., 2002). Two to 5 mice were
housed per cage in a 12-h light/dark cycle, with access to food and water ad libitum. All the
experiments were conducted by operators who were blind to the mouse genotypes. All
efforts were made to minimize the number of animals used and their suffering. All animals
undergoing seizures or that received the survival surgery for implantation of a microdrive or
microwire array were monitored daily for signs of poor health, and any animal that
developed moribund poor health was euthanized.
Behavioral seizure scoring
KA obtained from Sigma-Aldrich (St. Louis, MO, USA) or Tocris Bioscience (Ellisville,
MO, USA) was dissolved in 0.9% saline at 5 mg/mL to keep the injection volume below 0.5
ml and was prepared fresh on the day of each experiment. To establish the optimal dose of
KA that induced bilateral forelimb clonus and rearing in around 50% of animals, control
fNR1 mice were given intraperitoneal (i.p.) injections of KA, at doses ranging from 15 to 30
mg/kg body weight. Behavioral seizure activity was monitored for 2 h by video camera and
classified according to a modified Racine’s scale (Racine, 1972): stage 0, normal behavior;
stage 1, immobility; stage 2, repetitive movements, myoclonic twitch, or head bobbing;
stage 3, bilateral forelimb clonus and rearing; stage 4, continuous rearing and falling; stage
5, generalized tonic-clonic seizure. Based on the result in Fig. S1, a dose of 20 mg/kg was
established to elicit ‘stage 3′ seizures in about 40% of fNR1 control mice with no mortality,
and was used throughout the remainder of the experiments. Because no significant score
differences were observed when using KA obtained from Sigma-Aldrich or Tocris
Bioscience, the data obtained from each drug were combined for this study.
The mutant mice and their three strains of control littermates—fNR1, G32-4 Cre and B6—
were given i.p. injections of 20 mg/kg KA, and the maximal seizure score was scored every
5 min over the entire 2-h observation period per animal. To evaluate the seizure
susceptibility, the latency to ‘stage 3′ seizure was measured. If the animal did not show a
stage 3 seizure, 120 min was taken as the maximum latency. Occurrence (%) of ‘stage 4′
seizure score as well as a cumulative seizure score for each animal during the 2-h period
were averaged to calculate the rating scale value (± SEM) for each genotype. In order to
evaluate the effect of α-dendrotoxin (DTX), a potent enhancer of presynaptic GABA release,
on KA-induced seizures and subsequent events in the mutants, additional experiments were
conducted. For instance, we tested various doses of DTX to determine the optimal
subconvulsive dose of DTX. An i.p. injection of 0.5 mg/kg body weight induced
subconvulsive seizures such as grooming, head nodding and occasional wet-dog shaking,
but no convulsive seizure. Therefore, 0.5 mg/kg was chosen for the subsequent experiments.
All the drugs, except KA from Tocris Bioscience, were purchased from Sigma-Aldrich.
Histological procedures
Mice were deeply anesthetized with Avertin (i.p. injection of 0.03ml of 2.5% tribromo-
ethanol in tert-Amy alcohol per gram of body weight), and perfused transcardially with 4%
paraformaldehyde 1 day, 7 days, and 4 wk after the KA treatment. Untreated animals were
used as controls for each genotype. Brains were post-fixed in 4% paraformaldehyde
overnight, and 40 μm-thick Vibratome sections were prepared for the following
experiments. Our preliminary study showed no significant difference in histological features
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among the three control genotypes. Therefore, fNR1 mice were chosen as controls for all the
subsequent histological studies. In total, 30 fNR1 mice and 29 mutants were used.
To assess neuronal cellular degeneration, sections were stained with 0.2% Safranin O
solution (Polyscience, Inc. Warrington, PA, USA) for Nissl staining. Fluoro-Jade B
(Schmued & Hopkins, 2000) and neurosilver staining were used to demonstrate perikaryal
and terminal degeneration. Fluoro-Jade B staining was performed according to the
manufacturer’s instruction (Histo-Chem, Inc., Jefferson, AR, USA). Briefly, sections were
initially mounted, rehydrated with 80% ethanol and 70% ethanol, washed with distilled
water, and incubated in 0.06% potassium permanganate solution for 10 min. The sections
were then incubated in 0.0004% Fluoro-Jade B solution containing 0.1% glacial acetic acid
for 15 min at room temperature, washed, and mounted with distrene plasticizer xylene
(DPX; Electron Microscopy Sciences, Hatfield, PA, USA). For silver staining, free-floating
40-μm sections were processed with a silver impregnation protocol according to the
manufacturer’s instruction (NeuroSilver; FD Neurotechnologies Inc, Baltimore, MD, USA).
To evaluate the relationship between behavioral seizure score and excitotoxic injury, the
extent of the injury in the CA1 area was scored on a scale of 0-3, modified from the grading
system (Pulsinelli et al., 1982) as a ‘damage score’ using Nissl staining as follows; score 0,
no injury; score 1, 1-33%; score 2, 34-66%, score 3, 67-100% damage of CA1 cell layer.
Immunohistochemistry
To evaluate the functional integrity of hippocampal GABAergic neurons, 40 μm-thick
parasagittal Vibratome sections were washed with PBS and blocked with 5% normal goat
serum in PBS, followed by incubation at 4°C with gentle shaking in anti-glutamic acid
decarboxylase (GAD)-67 mAb (1:5000, Millipore, Billerica, MA, USA) for three nights.
Four sections per animal, which displayed ‘stage 4′ or more severe behavioral seizures, were
then incubated with Alexa488-conjugated anti-rat or mouse IgG (1:200, Molecular Probes,
Eugene, OR, USA) at room temperature for 2 h. The number of GAD67-positive cells in
CA1, CA3, and dentate gyrus (DG) was counted for each section, and the number of
positive cells in area CA1 was further counted for each stratum (stratum oriens, pyramidale,
radiatum or lacunosum-moleculare). The cell number was evaluated as a cell density, for
which the cell number was divided by the area of each subregion/stratum, and was averaged
per mouse. For double staining with anti-GAD67 and Fluoro-Jade B, sections after GAD67-
immunostaining were washed in three changes of PBS (10 min each) and placed on silane-
coated slide glasses, followed by a brief 1-min rinse in distilled water. The sections were
then stained with 0.00001% Fluoro-jade B in 0.1% acetic acid for 20 min at room
temperature, and washed in three changes of distilled water (for 1 min per wash) (Simpson
et al., 2001).
To assess GABA levels during KA-induced gamma oscillations, the animals (8 mutants and
8 controls) were sacrificed 20 min after a KA administration (20 mg/kg i.p.). Seven mutants
were treated with KA 90 min after pre-treatment with DTX (0.5 mg/kg i.p.), and then
sacrificed 20 min after KA injection. Twenty-μm thick parasagittal cryostat sections from
fresh-frozen brains were mounted on slides, followed by fixation with an ice-cold PBS
solution containing 2% paraformaldehyde/2.5% glutaraldehyde for 10 min. GABA was
labeled with anti-GABA primary antibody (1:1000, Millipore) and Alexa488-conjugated
anti-mouse secondary antibody (1:200, Molecular Probes, Eugene, OR, USA), and the
intensity of GABA-IR in the hippocampus was analyzed. To decrease variability in staining
across animals, samples from different animals were immunostained together. To avoid any
sampling bias that could affect GABA-IR quantification, two different parasagittal sections
from around 1.9 μm and 2.3 μm from bregma were selected per mouse. Staining images
were acquired and converted to grey scale, and analyzed with ImageJ software (NIH,
Bethesda, MD, USA). The intensity of GABA-immunoreactivity (IR) was measured as a
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mean grey value in the stratum pyramidale in CA1, the stratum lucidum in CA3, and corpus
callosum per section. The grey value of CA1 and CA3 was normalized by the value of
corpus callosum on the same section, and averaged per mouse.
In vivo multi-tetrode recording from area CA3
Naïve mice were implanted with a microdrive array consisting of seven independently
adjustable tetrodes, six of which were targeted to CA3 (stereotaxic coordinates from
bregma: 1.8 mm lateral; 2.0 mm posterior) and one to the corpus callosum to serve as the
reference. The mouse microdrive array for the tetrode recording was originally designed by
Dr. Linus D. Sun and was custom-made (Accelerated Technologies, Inc., Austin, TX, USA)
with some modifications. It was directly connected to an EIB-27-Micro (Neuralynx,
Bozeman, MT, USA), and unit recording was conducted using 32 channels of a Cheetah-64
recording system (Neuralynx). After 10 days of recovery from the implantation surgery, the
tetrodes were slowly lowered into the CA3 as the mice were sitting quietly in a small high-
walled enclosure (sleep box). Recordings began once stable units were obtained. Recording
sessions generally consisted of one or two “Run” epochs (20-30 min each) bracketed by
“sleep” sessions in which the animal rested quietly on a small platform outside of the
behavioral environment. “Run” sessions were conducted in a low walled L-shaped linear
track (length 77 cm and width 7 cm) placed near the center of a square black-curtained room
(10 ft × 10 ft). Diffuse room lighting was provided by low intensity spotlights focused on
four salient visual cues located on each of the walls of the recording room. Extracellular
action potentials during an animal’s run were recorded while the animal’s position was
tracked using a pair of infrared diodes placed 2 cm above its head. All the data acquired
during recording sessions were analyzed offline. In order to analyze individual cells in X-
clust, a manual clustering program (Wilson & McNaughton, 1993), Neuralynx timestamp
tracking files and Neuralynx video tracking files were converted to the files on a linux
template with the use of a custom interactive program running on a PC workstation. Action
potentials were assigned to individual cells based on a spike’s relative amplitude across the
four recording wires of a tetrode (Nakazawa et al., 2002). In order to be included for
analysis, isolated cells had to satisfy three criteria: (i) fire a minimum of 100 spikes during
the “Run” session, (ii) have a mean firing rate greater than 0.1 Hz, and (iii) have less than
0.5% of the cell spikes fall within a 1 ms refractory period. All isolated cells were divided
into two subclasses—pyramidal cells and interneurons—based on waveform and firing
characteristics. Putative pyramidal cells were defined as cells with relatively broad
waveforms (peak to trough width >300 ms) and a strong tendency to produce complex spike
bursts (CSI >3%) whereas putative interneurons had relatively narrow waveforms (peak to
trough width <240 ms) and few, if any, complex spike bursts (CSI <3%).
To determine the consequence of CA3-NR1 disruption on the firing of CA3 cells, we
measured several electrophysiological properties of hippocampal activity. First, we used two
measures to assess the output property of individual CA3 cells, mean firing rate and peak
firing rate. Second, we measured the bursting tendencies of hippocampal pyramidal cells
using two parameters, burst duration and burst spike frequency (the ratio of number of
spikes involved in a burst relative to the total number of spikes produced by a cell). Third,
we measured spike width (peak to trough width) as a measure of the intrinsic properties of
pyramidal cells.
Local field potential recording from area CA1
Five fNR1, three CA3-Cre mice and 10 mutant mice were employed for local field potential
(LFP) recording, during which animals received i.p. injection of 20 mg/kg KA. For mutants
receiving KA after DTX pretreatment (n=9), LFP recording was conducted as follows; 30
min recording of background activity, followed by 90 min recording after DTX pretreatment
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(0.5 mg/kg, i.p.), followed by over 90 min recording after KA treatment. Because DTX-
induced subconvulsive behavioral seizures were observed about 60 min after treatment as
previously described (Silveira et al., 1988), the last 30-min period before KA treatment was
analyzed.
The microwire array consists of eight Formvar-insulated nichrome wires (50 μm in
diameter; #762000, AM system, Carlsborg, WA, USA), which were aligned in a single
slanted row to vary the depth of recording (1 mm span), with an inter-electrode separation of
100 μm. Each microwire was connected with a silver paint to the pin of an 8-pin
subminiature headpiece connector (Mill-Max Mfg. Corp., Oyster Bay, NY, USA) and
securely covered by polyester shrink tubing. One pin was bent to attach an enamel-coated
copper ground wire (255 μm in diameter) to the skull during the surgery. All the connection
points were finally sealed and stabilized with a thin layer of dental acrylic. The impedance
of each electrode wire tip was between 0.2 to 0.5 MΩ. The microwire array was surgically-
implanted on the skull in the right hemisphere (Stereotaxic coordinates from bregma: 1.7
mm lateral; 2.0 mm posterior; 1.4 mm below the cortical surface at maximum depth) to
locate the electrode tips from the corpus callosum to the stratum pyramidale or radiatum of
area CA1, and fixed with a ground/reference wire to the skull with cranial screws and dental
acrylic. Electrode placement in all animals was confirmed after all the recording procedures
were completed, using the histological examination procedures described below. The mice
were allowed to recover from anesthesia before returning to their home cages, and were
monitored daily for their well-being.
After 10 days recovery from surgery, the microwire array of electrodes was connected to an
EIB-27-Micro via a custom-made adaptor, and LFP signals were filtered (bandwidth from
0.1 to 475 Hz), digitized and acquired at a sampling rate of 1.56 kHz per channel using 8
channels of a Cheetah-64 recording system (Neuralynx Inc.). Animals were i.p. injected
with KA at 20 mg/kg and LFPs were recorded in a rectangular open arena (24 cm × 18 cm)
for 30 min before and for at least 90 min after KA injection. LFP activity monitoring was
continued for at least 60 min 1 day (Day 2) and 7 days (Day 8) after injection. For mutants
receiving DTX pretreatment, LFP recording was conducted as follows; 30 min recording of
background activity, followed by 90 min recording after DTX pretreatment (0.5 mg/kg, i.p.),
followed by over 90 min recording after KA treatment. On Days 2 and 8, LFPs were
recorded in the same arena used on the day of injection. Because no significant difference
was observed in LFP activity between fNR1 and G32-4 Cre mice, the data from both
genotypes were combined as a control. On Day 11, the recording sites were micro-lesioned
by current injection to verify the location of the recording electrodes, and mice were
perfused with 4% formalin for Nissl staining.
KA-induced epileptic activity was obtained from the electrodes placed in CA1 cell layer and
analyzed with NeuroExplorer 4 software (Nex Technologies, Littleton, MA, USA). Epileptic
discharge in LFP recording was defined by high-frequency and high-voltage synchronous
spike activity and/or multi-spike complexes. Epileptiform activity was defined as a brief
event of ‘spike and wave’ discharge or ‘burst-like’ discharge with no continuous ictal
activity. The duration of epileptiform activity was measured from the onset of initial rise to
the point where LFP activity trace returned to baseline with no after-discharge period. LFP
activity during an entire recording period was also evaluated with spectrograms in
NeuroExplorer 4. To estimate the KA-induced low frequency (30-50 Hz) gamma band
oscillations, power spectrum density using Fast Fourier Transformation was analyzed within
2 min before onset of the first epileptic discharge. To calculate the peak power amplitude of
gamma band oscillation per animal, we first calculated baseline values of the power
spectrum density for each frequency, which was defined as on a linear line between values
at the frequencies of 30 Hz and 50 Hz. Peak power amplitude was then measured by
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subtracting the baseline value from its peak power value. Data from each animal were
analyzed using Statistica 7.0 software (StatSoft Inc., Tulsa, OK, USA).
Off-line analyses of sharp waves (SPW), ripples (R), and theta activity
The LFP signals were analyzed off-line with NeuroExplorer 4 software to visually explore
raw signals and calculate spectrograms. The electrode located at the corpus callosum served
as a reference electrode. Custom-made software written in a LabView Program (Vernier
Software & Technology, Beaverton, OR, USA) was used to detect and analyze SPWs,
ripples, and theta activity. Theta and SPW-R containing epochs were independently
analyzed after automatic segmentation of the raw signals in >15-sec epochs. Theta activity
was defined by calculating the theta/delta power amplitude ratio as previously described
(Csicsvari et al., 1999). Briefly, Fourier components of the theta (5-10 Hz) and delta (2-4
Hz) frequency bands were calculated in 5-s windows using a Hamming window. Theta
activity epochs were analyzed in segments with a theta/delta ratio >6. Mean amplitude and
peak-frequency of the theta band was calculated across all epochs per animal. Theta/delta
ratios <3 epochs were classified as non-theta periods or SPW-R associated periods and
subjected to ripple and SPW detection algorithms. Ripple events were extracted as
previously described (Buzsáki et al., 2003). The raw signals were digitally filtered (80-250
Hz using a Hamming window-based FIR band-pass digital filter) and background mean and
standard deviation (SD) were calculated from the power (root mean square) filtered-signals.
Epochs >7 SD from background mean were classified as a ripple; peak-to-trough amplitude
was individually measured and averaged for over 100 ripples per animal. In the same time
epochs, SPWs were detected in the unfiltered signals by applying a >4 SD background mean
exceeding the threshold. Mean-to-trough amplitude was measured for >100 SPWs and
averaged per animal. Histograms of SPW peak amplitudes were constructed per animal and
averaged for analysis of SPW event distribution across genotypes. In a bimodal event
distribution of the mutants obtained, the lower peak corresponded to ‘conventional’ SPW,
and a peak exceeding 1.8 mV amplitude was defined as a ‘giant SPW’. In addition, mean-to-
trough amplitude and occurrence were separately analyzed for ‘conventional’ and ‘giant’
SPWs.
Statistical Analysis
Data are presented as means and standard errors of the mean (SEMs). N-values are stated in
the figure legends. Statistical significance of electrophysiological data between means of
experimental and control groups was determined using Student’s t-test. Fisher’s exact test
and Kruskal-Wallis tests were performed to assess the differences in seizure susceptibility
between genotypes. Statistical analysis of immunohistochemical data was performed by
Kruskal-Wallis test followed by post-hoc with Mann-Whitney test with Bonferroni’s
correction for gray value analysis of GABA-IR. Analysis of variance (ANOVA) followed by
post-hoc Bonferroni test or Tukey test for all other analyses unless otherwise noted. A p-
value <0.05 indicates statistical significance.
Results
Reduced firing and impaired spatial representation in mutant CA3 pyramidal cells with
hypersynchronous sharp wave-ripple activity
A previous study from our laboratory showed that the place cell activity of CA1 pyramidal
cells in a familiar environment in mutant mice was apparently normal (Nakazawa et al.,
2002). To assess the basic firing and place cell properties of CA3 pyramidal cells in mutant
mice, we used an in vivo multi-tetrode recording technique in freely moving mice. Multiple
single units from hippocampal area CA3 were recorded as animals ran back and forth on a
familiar linear track; 24 pyramidal cells from 4 mutants and 20 pyramidal cells from 3 fNR1
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controls were quantitatively analyzed. There were dramatic decreases in the mean and peak
firing rates of mutant CA3 pyramidal cells compared to those of fNR1 mice (Table 1). The
bursting activities of mutant CA3 pyramidal cells, as measured by the duration of a single
burst and burst spike frequency—the percentage of spikes that occurred within bursts—also
decreased. No difference was observed in peak-to-trough spike width between the
genotypes. In addition, we observed defective CA3 place cell activity during animals’
exploration in a familiar open arena (Fig. 1), which could be attributed to impaired firing of
the mutant CA3 pyramidal cells.
Hypersynchronous SPW-R activity in mutant CA1 during immobility
SPW-R complexes originate in area CA3 and propagate to downstream targets including
area CA1 (Chrobak & Buzsáki, 1994,1996;Csicsvari et al., 2000;Maier et al., 2003;Both et
al., 2008). To evaluate the effects of CA3 NR1 ablation on CA1 network oscillations, we
assessed LFP activity recorded from area CA1 using 7 fNR1 control and 8 mutant mice in a
familiar small open arena for 30 min. We first defined theta and irregular slow activity
periods by calculating the ratio of the Fourier components of the theta (5-10 Hz) and delta
(2-4 Hz) frequency bands (Csicsvari et al., 1999). A ratio of >6 SD identified theta periods,
and epochs with <3 theta/delta ratio identified SPW-associated irregular slow activity period
(Hirase et al., 2001). In LFP recordings from the CA1 stratum radiatum where the SPW
activity is most robust in mice (Buzsáki et al., 2003) (Fig. 2B), the magnitude of mutant
SPW activity was overall much higher than that of fNR1 mice during SPW-associated
periods (Fig. 2A). Strikingly, the mutant SPW peak amplitudes were invariably bimodally
distributed (Fig. 2C), and the larger synchronous population activities exceeding 1.8 mV
amplitude, namely ‘giant SPW’, constituted about 12.7±2.0 % of total SPW events. In
contrast, almost no giant SPW activity was observed in the fNR1 control mice in any of the
recording periods. The average amplitude of mutant SPWs, excluding ‘giant SPWs’, was
also higher compared to fNR1 controls regardless of the duration of awake immobilization
periods (Fig. 2D; amplitude, 1.04±0.05 mV for mutants and 0.78±0.07 mV for fNR1,
Student’s t-test, P<0.05). Furthermore, the occurrence of SPWs showed a tendency to
increase (0.47±0.07 Hz for mutants and 0.31±0.05 Hz for fNR1, Student’s t-test, P=0.09).
Similarly, the averaged amplitude and the occurrence of fast oscillatory ripple activity
recorded from CA1 pyramidal cell layer in the mutants were both higher than those of fNR1
controls (Fig. 2, E and F; amplitude, 0.64±0.05 mV for mutants and 0.43±0.07 mV for
fNR1, Student’s t-test, P<0.05; occurrence, 0.53±0.03 Hz for mutants and 0.37±0.03 Hz for
fNR1, Student’s t-test, P<0.005). These results suggest that NR1 ablation in CA3 pyramidal
cells elicits a state of hyper-synchrony in the CA3 recurrent network, which propagates to
area CA1 thus generating larger and more frequent SPW-R events. It is also plausible that
the reduced firing of mutant CA1 GABAergic cells (Nakazawa et al., 2002) contributes to
the augmented SPW-R activity in area CA1.
The oscillatory activity during the theta periods in the mutants was normal overall. No
differences were observed in the power, peak frequency or the occurrence of theta bands
between the genotypes (Fig. 2G). Importantly, no ‘giant SPW’ events or paroxysmal
activities were detected during the theta period, which was consistent with the evidence in
the mutants showing normal CA1 place cell activity and spatial learning in the familiar
environment (Nakazawa et al., 2002,2003) as well as no behavioral seizures induced by
audiogenic or tactile stimuli (data not shown). These results suggest that the mutant mice
were overall not epileptic.
Mutants were more susceptible to KA-induced seizures
Because KA targets limbic structures and induces epileptic discharges (Ben-Ari et al.,
1981), we used it to test the long-standing hypothesis that hypersynchronous discharges
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reflected in CA3 SPWs play a causal role in the generation of limbic epilepsy (Prince, 1978;
Traub & Wong, 1982; Buzsáki, 1986). We first determined that an intraperitoneal (i.p.)
injection dose of 20 mg/kg animal body weight of KA induced minimal continuous rearing
and falling (‘stage 4′ seizures) and hippocampal damage in fNR1 control mice of B6
background (Fig. S1). Mice of four genotypes received i.p. KA injections—the mutant
mouse strain and three control groups: B6 wild-type, fNR1, and G32-4 Cre. Behavioral
seizures were evaluated for at least 2 h using a modified Racine’s score (Fig. 3). We found
that the latency to ‘stage 3′ seizures was significantly shorter in mutants than in controls, and
occurrence of ‘stage 4′ seizures, maximum seizure score, and the cumulative number of
seizures were all higher in the mutants than in the control genotypes. Two of the 14 mutants
experienced ‘stage 5′ seizures and one of them died after the treatment, while none of the
three control genotypes progressed to ‘stage 5′ seizures or died. These results suggest that
the mutant mice exhibit an increased susceptibility to KA-induced seizures.
Area CA1 selective neurodegeneration in mutant hippocampus was induced by KA
While the inbred C57BL/6 strain is resistant to neurodegeneration (Schauwecker & Steward,
1997; McKhann et al., 2003; McLin & Steward, 2006), increased seizure severity induced
by KA treatment may result in increased excitotoxicity in the mutant brain. To evaluate the
extent of excitotoxicity induced by KA at the dose of 20 mg/kg, Nissl staining was
conducted on parasagittal sections of mutants (Fig. 4, A and B) and fNR1 controls (Fig. S2,
A and B) that manifested ‘stage 4′ or more severe seizures during the first 2-h period after
treatment. In the hippocampus of mutants 1 day after KA injection, we observed extensive
excitotoxic alterations as revealed by highly condensed pyknotic nuclei in the CA1 cell
layer, but not in the CA2/CA3 or dentate gyrus (Fig. 4B). Four weeks after KA injection,
extensive cell loss was prominent in the CA1 pyramidal cell layer of mutants, while no
apparent degeneration was observed in the CA2/CA3 cell layer or dentate granule cell layer.
In contrast, almost no hippocampal cell loss was detected in the fNR1 mice in any subfield
at any stage following KA administration (Fig. S2B). Because the results in B6 wild-type
and G32-4 Cre mice were almost identical to those observed in fNR1 mice, we used the
results from fNR1 mice as the control genotype in all subsequent histological analyses.
To detect KA-induced neurodegeneration with higher sensitivity, fNR1 and mutant mice
underwent KA i.p. treatment and brain sections were processed for neurosilver staining.
Consistent with Nissl staining, most CA1 pyramidal cells were silver-stained from 1 day to 1
wk after KA treatment in all the mutants that manifested ‘stage 4′ or more severe seizures
(graph in Fig. 4C, F(3,32)=27.62 for genotype × time interaction in CA1, P<0.00001,
untreated mutant vs mutant at 1 day and 7 days after KA treatment, P<0.0005; fNR1 vs
mutant at 1 day and 7 days after KA treatment, P<0.0005). In contrast, almost no silver
impregnated cells were observed in area CA2/3, dentate gyrus, subiculum, entorhinal cortex,
or lateral septum (Fig. S2, C-F), suggesting that these brain areas are unlikely to be KA-
induced epileptic loci in the mutants. These stained cells largely disappeared within 4 wk
after treatment, probably due to immunological clearance of dead cells. In contrast, in
control fNR1 mice, almost no staining was found in any brain area, despite that fact that
some mice had shown equivalent stages of KA-induced seizure. To confirm the KA-induced
neurodegeneration, sections from both genotypes were stained with Fluoro-Jade B, a high
affinity fluorescent marker for the localization of neuronal degeneration (Schmued &
Hopkins, 2000). In the mutant hippocampus, distribution of Fluoro-Jade B stained cells
largely coincided with the silver impregnated cells, confirming that neurodegeneration was
localized to area CA1 in the mutant hippocampus (Fig. 4E).
To further elucidate this issue, we examined whether seizure severity correlated with KA-
induced excitotoxic cell damage in the hippocampus. We used Nissl staining for
morphological analyses of fNR1 (n=30) and mutant (n=29) mice 1 to 4 wk after KA
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treatment, including the mice depicted in Fig. 3 and Fig. 4, A-C. Figure 4D shows 3-D
histogram plots of the maximum seizure score for the first 2 h after KA treatment, compared
to subsequent damage in the CA1 cell layer for each genotype. Mutants showed a clear
correlation between the severity of seizure and the extent of CA1 cell damage, but the two
scores were not correlated in fNR1 controls (Pearson coefficient for mutant, r=0.74,
P<0.00005; Pearson coefficient for fNR1, r=0.27, P=0.14; genotype effect, P<0.05).
Furthermore, the mutant damage scores were bimodally distributed, and about 40% of
mutants with less severe seizure scores exhibited no CA1 degeneration. In contrast, most
fNR1 mice (28 out of 30) showed CA1 cell death regardless of the severity of seizure scores.
KA-induced epileptic discharges with attenuated gamma oscillation in area CA1 of
mutants
To explore the underlying mechanisms by which CA3 NR1 ablation resulted in KA-induced
excitotoxic cell death in area CA1, we assessed LFP activity in the CA1. LFP recordings
were performed during the first 90 min, 1 and 7 days after KA injection, using electrodes
implanted into the dorsal area CA1 in fNR1 (n=5) and Cre (n=3) control mice and in mutant
mice (n=10). All of the KA-treated animals carrying a microwire array exhibited typical
behavioral seizures, similar to those described in Fig. 5A, lasting several hours and
subsiding spontaneously on that day. Because the results from fNR1 and Cre mice were
almost identical, these results were combined and treated as a “control” genotype. During
the acute phase, highly synchronous epileptic discharges repeatedly occurred in area CA1 of
both control (trace #1) and mutant (traces #3 and #5) mice (Fig. 5A). The latency to
epileptic discharges after KA injection was significantly shorter in mutants than in control
mice (Fig. 5B). The occurrence of epileptic discharge events during the first 90 min after
KA treatment was also higher in mutants (Fig. 5C). Cumulative epileptic discharge duration
during this period was also longer in mutants than controls (Fig. 5D). It is conceivable that
the magnitude of mutant epileptic discharges could contribute to CA1 neurodegeneration. In
fact, when mutants were subdivided into two groups according to the CA1 damage score
shown in the middle panel of Fig. 9A, the magnitude of epileptic discharge events was much
more robust in the mutants that eventually showed cell death in area CA1 (Group B)
compared to those that did not (Group A) (Fig. 5, C and D).
In control mice, another prominent KA-induced oscillatory activity was low-frequency
(30-50 Hz) gamma band oscillation that appeared approximately 15-20 min after KA
injection and 10 min before the onset of the first epileptic discharge (trace #2 in Fig. 5, A
and E). This is consistent with reports of KA-induced 30-40 Hz oscillatory synchronous
activity in the rodent hippocampus in vivo (Medvedev et al., 2000; Khazipov & Holmes,
2003; Sakatani et al., 2008). However, the LFP power spectrogram of mutant CA1 (Fig. 5F)
revealed a significantly lower magnitude of 30-50 Hz gamma band oscillations during this
period in the mutants than in the controls (trace #6 in Fig. 5, A and E). Remarkably, KA-
induced gamma band oscillatory activity almost disappeared in Group B mutants (those with
cell death); in contrast, this activity remained observable in Group A mutants (those without
cell death; Fig. 5G). Because Group A mutants exhibited gamma oscillations despite a short
latency to epileptic discharges (Fig. 5B), this effect in Group B mutants did not appear to be
due to obscured detection of gamma oscillations by epileptic discharges. These results
suggest that the magnitude of 30-50 Hz gamma oscillations before onset of epileptic
discharges was inversely correlated with the degree of CA1 excitotoxicity.
Epileptiform activity was sustained in mutant CA1
To further explore the process leading to CA1 neurodegeneration in the mutants, LFP
recording was continued on the day following KA injection. LFP activity in the CA1 area of
fNR1 or Cre control mice showed no continuous ictal discharges and was almost
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indistinguishable to that observed before KA treatment. However, area CA1 in the mutants
exhibited epileptiform activity characteristic of large-amplitude spike-like discharges on
Day 2 (Fig. 6A), although they displayed no continuous ictal discharges. Among mutants,
Group A (non-cell death) mutant mice displayed ‘spike and wave’ discharges superimposed
upon normal background activity. In contrast, Group B mutant mice, having undergone
massive CA1 degeneration, showed polyspike discharges with longer durations on top of the
suppressed background activity. Quantitative analysis revealed that the occurrence of such
epileptiform activity, which was rarely observed in the controls, was higher in Group B than
Group A mutants (Fig. 6B). The duration of individual epileptiform activity was also longer
in Group B mutants (Fig. 6C). Remarkably, polyspike discharge-type epileptiform activity
was still present in Group B mutants at least 7 days after KA treatment, whereas simple
‘spike and wave’ discharges were rarely observed in Group A mutants (Fig. 6D). These
results suggest that the massive CA1 neurodegeneration observed in Group B mutants
resulted from the polyspike discharge-type epileptiform activity observed on Day 2.
KA-induced degeneration of mutant CA1 GABAergic cells
Attenuation of low frequency gamma oscillations in the acute phase and the subsequent
epileptiform activity on the following days in the group B mutants could reflect a deficit in
CA1 GABAergic network activity upon KA administration. To evaluate the integrity of
hippocampal GABAergic networks, we quantified the neurosilver-positive cells in the
mutant CA1 subfield in neurosilver-stained sections shown in Fig. 4C. Prominent increases
in neurosilver-positive cells were observed not only in the cell layer (stratum pyramidale)
but also in other strata 1 day after KA treatment (Fig. 7A), suggesting neurodegeneration of
CA1 interneurons. Fluoro Jade-B positive sections (Fig. 4E) were also immunostained with
anti-GAD67, the GABA synthesizing enzyme, and double-labeling confirmed degeneration
of mutant GABAergic interneurons in area CA1 (Fig. 7B).
To further examine the extent of the damage to the degenerated interneurons, we quantified
the GAD67-positive cells in untreated and KA-treated animals which showed ‘stage 4′ or
more severe seizures (Fig. 7C). The number of GAD67-positive cells in CA1 of fNR1
control mice decreased 1 day after KA treatment but returned to the levels seen in untreated
mice within 1 wk (Fig. 7D). In contrast, the number of GAD67-positive cells in the CA1
subfield of the mutants decreased to less than 50% of fNR1 control mice 1 day after
injection and was unchanged 4 wk after treatment. In the mutants, regional analysis revealed
a severe and permanent KA-induced reduction of GAD67-positive cells in all strata
compared with fNR1 mice, except for cells in the lacunosum-moleculare (Fig. 7E). Notably,
the total number of GAD67-positive cells in stratum oriens (~150 cells/mm2) and stratum
radiatum (~50 cells/mm2) (see ‘untreated’ cell number in Fig. 7E) was similar to the number
of mutant neurosilver-positive cells in the same strata 1 day after KA treatment (Fig. 7A),
suggesting that while most GABAergic neurons in the mutants transiently suffered
neurodegeneration upon KA administration, at least 60% of GABAergic cells in these CA1
strata permanently lost GAD67-IR, presumably coinciding with cell death. On the other
hand, the number of mutant neurosilver-positive cells in stratum lacunosum-moleculare (~50
cells/mm2) was far less than the total number of GAD67-positive cells in the same strata
(~200 cells/mm2). Their GAD67 activity was also largely restored 1 wk after KA treatment.
Because the main input to lacunosum-moleculare interneurons comes from the entorhinal
cortex (Klausberger & Somogyi, 2008) (not from the CA3), the results suggest that CA1
GABAergic cells receiving reduced output selectively from CA3 suffered severe
neurodegenerative change upon KA treatment.
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Pretreatment with DTX restored mutant KA-induced gamma oscillation, GAD67 activity,
and resistance to CA1 neurodegeneration
GABAergic interneuron activity suppresses excitotoxicity during seizures (Ylinen et al.
1991; Mody, 1998). Therefore, we wondered whether boosting GABA levels before the
onset of the first seizure discharge could protect against CA1 neurodegeneration in the
mutants. To test this, we used DTX, a D-type potassium channel blocker, because it acts on
presynaptic voltage-gated potassium channels of cortical interneurons (Weller et al., 1985;
Richards et al., 2000; Cunningham & Jones, 2001; Shimada et al., 2007) and is a potent
enhancer of presynaptic GABA release. The extent to which DTX pretreatment affected
presynaptic release was assessed by anti-GABA-IR in the CA1 cell layer where axon
terminals of GABAergic interneurons exuberantly arborize. We first confirmed that there
were no obvious effects of a subconvulsive dose of DTX (0.5 mg/kg i.p.) prior to KA
treatment on the CA1 SPW-R activity in the mutants (Fig. 8). This was not surprising
because SPW-R activity is generated in area CA3 where GABAergic function seemed to be
normal in the mutants (Fig. S3).
We then evaluated several parameters for LFP activity and CA1 excitotoxicity by injecting
KA 90 min after DTX pretreatment. Fig. 9A shows the histograms of behavioral seizure
scores for each animal after KA injection as well as the CA1 damage score 10 days after the
treatment. We found that the behavioral seizure score (Fig. 9B) as well as the number and
duration of mutant epileptic discharges (Fig. 9C) were not affected by DTX-pretreatment,
which was unexpected. Furthermore, the damage scores in DTX-pretreated mutants were
dramatically lower than in saline-pretreated mutants (Fig. 9, A and B). Remarkably, DTX
pretreatment in mutants also evoked robust low frequency gamma oscillations before the
onset of seizure discharges (Fig. 10A, trace #1 for seizure discharge and trace #2 for gamma
oscillation), and the magnitude of gamma oscillations was equivalent to those observed in
fNR1 or Cre control mice (Fig. 10B), suggesting that DTX-sensitive, voltage-gated
potassium channels are instrumental in synchronizing KA-induced gamma oscillations.
In parallel, KA-induced GABA increases were assessed by comparing GABA-IR levels in
CA1 to the IR level of the corpus callosum where few GABAergic cells are localized (Fig.
10, C and D). GABA-IR levels in the CA1 cell layer 20 min after KA treatment were
significantly higher than in the corpus callosum in controls, which is consistent with
previous reports demonstrating KA-induced GABA release in the hippocampus (Zhang et
al., 1990; Ding et al., 1998). Remarkably, the CA1 cell layer in mutants showed no
increased GABA levels in response to KA injection and this was significantly rescued by
pretreatment with DTX. The deficit in KA-induced GABA increases appeared to be specific
to area CA1 in mutants because no difference was observed in other subfields.
To further evaluate the effects of DTX-induced gamma oscillations on subsequent days, the
peak power amplitude of gamma oscillations and the occurrence of epileptiform activity on
Day 2 were plotted for all the animals, including the mutants pretreated with DTX (Fig.
10E). We found that the number (Fig. 10E) and duration (Fig. 10F) of epileptiform activity
in the pretreated mutants was decreased compared to the saline-pretreated mutants.
Moreover, the number of CA1 GAD67-positive cells in mutants was also equivalent to that
found in fNR1 mice 1 wk later (Fig. 10G), suggesting that DTX-induced low frequency
gamma band oscillations restored CA1 GABAergic cell function. Accordingly, 10 days after
DTX and KA treatment, almost no CA1 degeneration was observed in the mutants as
revealed by Neurosilver staining (Fig. 9B).
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DISCUSSION
The present study had several salient findings. Specifically, (1) CA3-NR1 KO mutants
displayed reduced CA3 pyramidal cell firing, impaired CA3 spatial representation, and
augmented SPW-R activity; (2) systemic KA administration to the mutants resulted in
impaired KA-induced GABAergic activation and 30-50 Hz gamma oscillations. These were
accompanied by augmented seizure discharges, thereby leading to massive and strikingly
selective neurodegeneration in area CA1; (3) in the mutants, the magnitude of KA-induced
gamma oscillations was inversely correlated with the magnitude of epileptiform activity, the
degree of CA1 degeneration, and the viability of GAD67-positive cells in the days following
KA treatment; and (4) pretreatment with DTX, which restored CA1 GABA levels,
maintained mutant KA-induced gamma oscillations and GAD67-positivity, thereby
preventing the mutant CA1 cells from excitotoxic cell death. Taken together, the results
indicate that a lack of KA-induced gamma oscillations before onset of seizure discharges
correlates with prolonged seizure activity and CA1 excitotoxicity, suggesting that persistent
gamma oscillations predict resilience to excitotoxic insults.
Increased susceptibility to KA-induced seizure and CA1 excitotoxicity following CA3 NR1
ablation
To explore the relationship between gamma oscillations and excitotoxicity, it was essential
to employ CA3-NR1 KO mice (referred to as “mutants” throughout this manuscript). In
these mice, two possibly interrelated events were observed following genetic NR1 ablation
of CA3 pyramidal cells during adulthood (Nakazawa et al., 2002)—a dramatic decrease in
CA3 pyramidal cell firing/bursting and augmented SPW-R activity. It is not obvious how
functional ablation of CA3 NRs could decrease action potential generation. In fact, firing
rates of CA1 pyramidal cells lacking the same NR1 subunit were almost the same as those
of control mice (McHugh et al., 1996). The results obtained here could simply be due to the
mutual reduction of afferent drive from nearby CA3 pyramidal cells as well as the inhibition
of cell firing by CA3 interneurons (Freund & Buzsáki, 1996). Another possibility, which is
not mutually exclusive, is that CA3 NRs could contribute to normal excitatory synaptic
transmission, as described in adult visual cortex (Miller et al., 1989), sensory thalamus
(Kemp & Sillito, 1982; Salt, 1986) and the red nucleus (Davies et al., 1986), or could even
contribute to action potential generation (Zhao et al., 2005).
On the other hand, increased SPW-R activity during immobility is paradoxical given that
CA3 recurrent network activity is low since generation of CA3 SPW-R apparently requires
CA3 recurrent network activity (Csicsvari et al., 2000; Behrens et al., 2005). While NR
antagonists prevent the induction of the SPW-R complex (Behrens et al., 2005), NRs seem
to be unnecessary for maintaining spontaneous SPW-Rs once the SPW-Rs are established
(Behrens et al., 2005) or in the ventral portions of the hippocampal CA3 where spontaneous
SPW-Rs are observed (Maier et al., 2003; Papatheodoropoulos & Kostopoulos, 2002;
Colgin et al., 2004). Rather, the magnitude of CA3 SPW-Rs nearly doubled following the
application of an NR antagonist in rat slices, perhaps via mechanisms that involve decreased
Ca2+ influx through NRs and a subsequent inactivation of SK type2 Ca2+-activated
potassium channels mediating afterhyperpolarization (Colgin et al., 2004). Because CA3
NR1 was eliminated along the longitudinal axis including ventral CA3 in the mutants
(Nakazawa et al., 2002), spontaneous SPW-Rs could become larger in ventral CA3 after
postadolescent NR1 ablation, subsequently spreading to dorsal CA3 and further to area
CA1. While the mechanisms underlying the generation of spontaneous ‘giant SPWs’ are
unknown, impaired Ca2+-activated afterhyperpolarization could play a role because its
abnormal regulation may contribute to epileptiform discharges (Fernández de Sevilla et al.,
2006). Alternatively, ‘giant SPWs’ could be a consequence of decreased CA3 pyramidal cell
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firing because spontaneous oscillatory bursting seems to be a common behavior of
tetrodotoxin (TTX)-treated neurons (Ramakers et al., 1990; Trasande & Ramirez, 2007).
Consequently, in this study, the mutants displayed increased susceptibility to KA-induced
seizures and CA1 excitotoxicity, due to impaired GABAergic function in area CA1 of the
hippocampus, and abnormally high SPW-R activity during periods of immobility. One
plausible explanation for the remarkably selective CA1 neurodegeneration seen here is that
reduced afferent drive from CA3 to CA1 interneurons in a feed-forward manner leads to a
coherent loss of postsynaptic inhibition in area CA1 upon KA treatment, thus rendering CA1
cells vulnerable to excitotoxicity. Interestingly, almost no CA3 cell death in mutants was
observed despite reduced afferent drive from the recurrent network.
The KA dose used here for systemic injection (20 mg/kg i.p.) was instrumental in
determining the cellular process by which KA injection led to neurodegeneration of mutant
CA1 cells. Approximately half of the mutants manifested massive and irreversible cell loss
in the CA1 cell layer; in contrast, the other half displayed almost no cell death (Figs. 4D and
9A). This non-cell death group (Group A mutants) became an excellent animal control in the
same genotype to evaluate the process of CA1 degeneration for the Group B mutants. The
high variability to KA-induced excitotoxicity among the mutants could be due to that the
KA dose used, 20 mg/kg, is close to the threshold dose to evoke the clonic seizures (‘stage 3′
seizure or more, Fig. S1).
KA-evoked GABA release to generate gamma oscillations, preventing CA1 excitotoxicity
Systemic KA injection increases extracellular GABA levels in rodent hippocampus (Zhang
et al., 1990; Ding et al., 1998), which could be attributed to direct KA action on GluR5-
containing KA receptors that are located on presynaptic axon terminals of interneurons and
release GABA (Khalilov et al., 2002; Fisahn et al., 2004). In the present study, KA injection
in mutants did not increase GABA levels or trigger gamma oscillations in area CA1 in the
same way as in control animals. However, it is possible that chronic reduction of afferent
drives from the CA3 area of mutants could result in KA-induced deficiencies in GABA
release from CA1 interneurons. To rescue this deficit, we used DTX, a potent enhancer of
presynaptic GABA release. DTX is a selective blocker of D-type voltage-gated potassium
channels (Kv1.1, Kv1.2, and Kv1.6) (Judge & Bever, 2006) and stimulates GABA release in
rat cortical synaptosome fractions (Weller et al., 1985), rat entorhinal cortex (Cunningham
& Jones, 2001), and substantia nigra (Shimada et al., 2007); glutamate release action seems
to be weak in rat hippocampus (Richards et al., 2000) and entorhinal cortex (Cunningham &
Jones, 2001). As expected, administration of DTX prior to KA treatment restored the CA1
GABA levels in the area CA1 but, remarkably, preserved KA-induced gamma oscillations.
Released GABA, in turn, stimulates the GABAA receptors of other GABAergic cells and/or
CA1 pyramidal cells, maintaining KA-triggered gamma oscillations (Bartos et al., 2007;
Mann & Paulsen, 2007). In fact, a recent study provides firm evidence that gamma
oscillations arise from a network of mutually connected fast-spiking GABAergic neurons
(Cardin et al., 2009). Therefore, restoration of gamma oscillations in area CA1 by DTX
treatment could be attributed to an enhanced GABA release, regardless of DTX actions on
other neurotransmitters. Interestingly, KA-induced extracellular secretion of the calcium-
binding protein S100B from astrocytes has recently been shown to enhance KA-induced
gamma oscillations (Sakatani et al., 2008). Therefore, we cannot exclude the possibility that
other mechanisms enhance the gamma oscillations upon KA administration.
Status epilepticus has long been implicated in brain damage, and several studies suggest a
positive association between adverse outcomes and duration of status epilepticus (Norman,
1964; Corsellis & Bruton, 1983). In this study, we found that DTX pretreatment did not alter
the magnitude of KA-induced seizure discharges, possibly due to the influence of enhanced
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SPW-R activity in the mutants. Therefore, KA-induced seizure severity during the first 2 h
of status epilepticus did not necessarily determine the magnitude of excitotoxicity. In
contrast, protection from excitotoxicity by pretreatment with DTX, accompanied by the re-
emergence of persistent gamma oscillations, suggests that KA-induced GABA release is
critical for the prevention of CA1 neurodegeneration. Furthermore, DTX pretreatment also
significantly suppressed KA-induced epileptiform activity the following day. This suggests
that KA-induced GABA release by DTX pretreatment may prevent the initiation of
subsequent processes leading to excitotoxicity, including epileptiform activity, on the
following day (Fig. 11).
Clinical implications
What is more important in this study is that the magnitude of low frequency gamma
oscillations prior to the onset of behavioral seizures was inversely correlated with the
occurrence of epileptiform activity on subsequent days (Fig. 10E). This is a finding of
considerable clinical importance, because persistent gamma oscillations, which are
measurable via EEG recordings in humans, could be used as an alternative prognostic
indicator for predicting resilience to excitotoxicity. Interestingly, the prognostic value of
oscillatory activity for seizure outcomes may vary, depending on the oscillation frequencies.
Fast gamma (60-100 Hz) oscillations have been reported to predict the development of ictal
seizures in human neocortical epilepsy patients (Worrell et al., 2004). In contrast, ‘low-
voltage fast activity’ (>13 Hz), beta (15-30 Hz), or gamma frequency in the neocortex were
more prevalent in favorable outcome groups after resective surgery (Lee et al., 2000;Park et
al., 2002). The present findings predicted not only a good prognostic value of hippocampal
low frequency gamma oscillations for prolonged epileptiform activity but also
excitotoxicity. Whether the identification of low frequency gamma oscillations could be of
prognostic value in the treatment of epilepsy patients remains unknown, but clearly warrants
further research.
The use of cell-type specific transgenic mutants also demonstrated that CA3 pyramidal cell-
specific alterations are capable of initiating epilepsy after excitotoxic insults. It has long
been suspected that the CA3 recurrent network is one of the critical loci in medial temporal
lobe epilepsy (Buzsáki, 1986; Traub et al., 1989). Recently, Nosten-Bertrand and colleagues
(Nosten-Bertrand et al., 2008) reported that a dysplastic CA3 subfield in hippocampal slices
of doublecortin (Dcx) knockout mice generates SPW-like spontaneous activity and increases
susceptibility to epilepsy. Interestingly, Dcx mutations in humans cause type I lissencephaly
to subcortical laminar heterotopia (SCLH), which are associated with epilepsy (Guerrini &
Marini, 2006). While it is unclear to what extent Dcx mutation-derived defects are confined
to the CA3 subfield in SCLH patients, the present study, along with these recent clinical
data, suggest that the CA3 subfield may indeed be a site of epileptogenesis in humans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Dr. Linus D. Sun and Ms. Catherine J. Cravens for technical assistance, Drs. Brian Condie and John
Rubenstein for providing GAD67 cDNA plasmid, and Drs. György Buzsáki, Dax Hoffman, Karen N. Gale, Brita
Fritsch, Kim Christian, and Ioline Henter for valuable advice and critical reading of this manuscript. This research
was supported by the Intramural Research Program of the National Institute of Mental Health and by NIH Grant
R01-MH078821 to ST. SJ was supported in part by a Japan Society for the Promotion of Science (JSPS)
fellowship.
Jinde et al. Page 15
Eur J Neurosci. Author manuscript; available in PMC 2010 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Abbreviations
B6 C57BL/6
DTX α-dendrotoxin
fNR1 floxed-NR1
GABA γ-Aminobutyric acid
GAD67 67-kDa isoform of glutamic acid decarboxylase
IR immunoreactivity
KA kainic acid
LFP local field potential
SPW-R sharp wave-ripple
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FIG. 1. Mutants are impaired in CA3 place cell activity in a novel and familiar arena
Representative place fields from the same CA3 complex spiking cells recorded in a novel
(Day 1) and familiar (Day 2) rectangular low-walled arena (90 × 60 cm). Firing-rate maps
are scaled to the same maximum firing rate per cell across days, as indicated at the upper
right corner of the maps. Analysis was restricted to periods when animals were running >2
cm/sec and firing rate was calculated for pixels visited >10 times. The mutant mice
displayed defective CA3 place cell activity, while CA3 cells in fNR1 control mice formed
stable and spatially confined place fields.
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FIG. 2. Augmented SPW-R activity and normal theta wave activity in area CA1 of the mutants
(A) Representative LFP traces including theta and SPW-associated periods in fNR1 (left)
and mutant (right) mice recorded from CA1 stratum radiatum. Typical traces of theta waves,
‘conventional’ SPWs and ‘giant SPWs’ are magnified below. LFP signals were filtered at
80-250 Hz to detect ripples and at 5-12 Hz to detect theta waves.
(B) Location of individual electrodes implanted in CA1 stratum radiatum for SPW analysis.
(C) Distribution of the peak amplitude of SPW in fNR1 control (black rhomboid) and
mutant (red circle) mice. Strikingly, mutants showed clear bimodal distribution of SPW
peak amplitude. Events with peak amplitude exceeding 1.8 mV were defined as ‘giant
SPW’, which appeared only in mutants.
(D) The amplitude (left) and the occurrence (right) of conventional SPW in fNR1 and
mutant mice during SPW-associated periods. Mutants displayed higher amplitudes
(Student’s t-test, *P<0.05) and increased tendency towards ‘conventional’ SPWs (Student’s
t-test, P=0.09).
(E) Location of individual electrodes implanted in CA1 stratum pyramidale for ripple
analysis.
(F) The amplitude (left) and the occurrence (right) of ripples in fNR1 and mutant mice
during SPW-associated period. Ripple amplitude and occurrence in mutant mice were higher
than in fNR1 controls. Student’s t-test, ***P<0.005, *P<0.05.
(G) Power (left) and peak frequency (middle) of theta oscillations and theta-delta ratio
(right) are shown. Theta/delta ratio was defined as power in the theta peak frequency range
(5-10 Hz) divided by power in the delta peak frequency range (2-4 Hz). No significant
differences in theta properties were observed between fNR1 and mutant mice, suggesting
normal theta activity in mutants. Black bar, control mice; red bar, mutant mice. Number in
parentheses indicates the number of animals.
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FIG. 3. CA3-NR1 KO mice show higher susceptibility to KA-induced seizures
(A) Time course of seizure severity in each animal from the mutant and three control
genotypes (B6, fNR1 and Cre) following KA treatment (20 mg/kg, i.p.). The maximum
seizure score of each animal was measured every 5 min over a 2-h period. Timescale in one
box was 5 min.
(B) The latency to ‘stage 3′ seizures—forelimb clonus and rearing—was shorter in mutants
than other genotypes. Note that, if the animal did not show stage 3 seizure, the latency was
regarded as 120 min. Kruskal-Wallis test, *P<0.05.
(C) The occurrence of ‘stage 4′ seizures—continuous rearing and falling—was higher in
mutants than other genotypes. Fisher’s exact test, *P<0.05.
(D and E) Mutant mice showed a higher severity of seizure than any of the control
genotypes. Columns represent the averaged maximum seizure score (D) and cumulative
seizure score (E) measured over a 2-h period after KA injection. Kruskal-Wallis test,
*P<0.05. Black bar, fNR1 mice; red bar, mutant mice. The number in parentheses indicates
the number of animals.
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FIG. 4. KA-treated mutant mice showed massive neurodegeneration in area CA1
(A) Nissl-stained parasagittal brain sections of mutant untreated (left) and mutant 4 wk after
KA treatment (right). KA-treated mutants showed severe neuronal loss in area CA1
(indicated by arrowheads).
(B) Magnified hippocampal subfields, CA1, CA3 and dentate gyrus (DG) in mutant mice
untreated, or 1 day, 7 days and 4 wk after KA injection. Each bottom panel shows a higher
magnification of the boxed area in the mutant CA1. Note that highly condensed pyknotic
nuclei, a typical sign of damaged nuclei, were observed in the mutant CA1 pyramidal cell
layer from 1 day to 7 days after KA injection, eventually disappearing by 4 wk post-
treatment.
(C) Neurosilver staining showed massive neuronal degeneration in mutant CA1 7 days after
KA treatment. Neurosilver-positive cells were not detected in the fNR1 control
hippocampus. The graph on the right shows the number of neurosilver-positive cells in the
hippocampal subfields of both genotypes. The number of neurosilver-positive cells in the
mutant CA1 was significantly higher than in controls at 1-day or 7-day post-injection.
Tukey’s post hoc test, untreated mutant vs mutant at 1 day and 7 days after KA
treatment, ‡P<0.0005; fNR1 vs mutant at 1 day and 7 days after KA treatment, #P<0.0005.
Black bar, fNR1 mice; red bar, mutant mice. The number in parentheses indicates the
number of animals for each time point.
(D) 3D plots of maximum seizure scores (x axis) vs damage scores (y axis) of fNR1 (left)
and mutant (right) mice 1 to 4 wk after KA treatment. Z axis shows number of animals.
Neuronal damage was evaluated according to the damage score scale (see Methods). Black
bar, fNR1 mice; red bar, mutant mice.
(E) Fluoro-Jade B staining revealed massive neuronal degeneration predominantly in the
CA1 of the mutant mice 1 day, 7 days, and 4 wk after KA treatment, while almost no
staining was observed in fNR1 controls and in untreated mouse sections regardless of
genotype.
Jinde et al. Page 23
Eur J Neurosci. Author manuscript; available in PMC 2010 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIG. 5. Increased epileptic discharges with diminished gamma oscillation upon KA injection
(A) Representative spectrograms of KA-induced LFP activity from fNR1 control (left) and
mutants (middle and right). Mutants were subdivided into two groups; Group A (middle),
which did not show cell death, and Group B (right), in which CA1 cell death was eventually
observed, based on the CA1 damage score shown in the middle panel of Fig. 9A. Arrows
indicate timing of KA i.p. injection. Color: Log of power spectral densities. Epileptic
discharge traces of a representative fNR1 mouse (marked as #1 in spectrogram) and Group
A and Group B mutant mice (marked as #3 and #5, respectively) are also shown below each
spectrogram.
(B) Left: the latency to epileptic discharges after KA treatment was shorter in mutant mice
(n=10) than controls (n=8, 5 fNR1 and 3 Cre mice). Right: Group A ‘non-cell death’
mutants (n=5) and Group B ‘cell death’ mutants (n=5), as defined above. Student’s t-test,
*P<0.05. No difference in latency to epileptic discharge was noted between the two mutant
groups. Student’s t-test, n.s., not significant.
(C) Left: epileptic discharges during 90 min after KA treatment occurred in mutant mice
(n=10) more frequently than controls (n=8, 5 fNR1 and 3 Cre mice). Right: the number of
discharges was higher in Group B mutants than in Group A mutants. Student’s t-test,
*P<0.05.
(D) Left: average duration of individual epileptic discharge events was longer in mutants
compared to controls. Right: among mutants, Group B mutants showed longer epileptic
discharge duration than Group A mutants. Student’s t-test, *P<0.05.
(E) Representative traces of 30-50 Hz gamma band oscillatory activity, which preceded the
first epileptic discharge, in fNR1 (upper) and Group B mutant (bottom) mice (marked as #2
and #6, respectively in Fig. 5A). Boxed periods in each upper trace are magnified in bottom
traces.
(F) LFP power spectra in area CA1. The power amplitude of 30-50 Hz gamma band during
2 min before the onset of the first epileptic discharge was significantly diminished in
mutants (red-filled circle) compared to controls (filled rhomboid). Student’s t-test, #P<0.01
for 35 Hz, *P<0.05 for 37.5 Hz.
(G) Left: peak power amplitude of 30-50 Hz gamma band oscillation in mutants was
significantly attenuated compared to controls. Right: this attenuation was more prominent in
Group B mutants compared to Group A mutants. Student’s t-test, ***P<0.00005, *P<0.05.
Black bar, fNR1 control mice; red bar, mutant mice; open red bar, Group A mutant mice;
pink-filled bar, Group B mutant mice. The number in parentheses indicates the number of
animals.
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FIG. 6. Sustained epileptiform activity leading to cell death in area CA1 of mutant mice
(A) Representative LFP activity traces recorded 1 day after KA in fNR1 controls (left),
Group A ‘non-cell death’ mutants (middle) and Group B ‘cell death’ mutants (right). Boxed
periods in each upper trace are magnified in bottom trace. Epileptiform activity was present
in mutants 1 day after treatment; controls showed almost normal activity. Group A mutants
sporadically showed spike and wave discharges with concomitant background activity
whereas Group B mutants displayed a burst suppression-like pattern.
(B) Group B mutants showed higher occurrence of epileptiform activity than Group A
mutants (right). Almost no activity was observed in control mice (left). Mann-Whitney U-
test, **P<0.005.
(C) Group B mutants showed longer duration of brief epileptiform activity events than
Group A mutants. Student’s t-test, **P<0.005.
(D) Burst-like epileptiform activities were still detected in Group B mutants 7 days after KA
treatment (right), but were rarely observed in Group A mutants or control mice (left). Mann-
Whitney U-test, *P<0.05. Black bar, fNR1 mice; red bar, mutant mice; open red bar, Group
A mutant mice; pink bar, Group B mutant mice. The number in parentheses indicates the
number of animals.
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FIG. 7. Massive neurodegeneration of mutant CA1 interneurons after KA treatment
(A) Quantification of neurosilver-positive cell number in the mutant CA1 subfield in
neurosilver-stained sections in Fig. 4C. One day after KA treatment, neurosilver-positive
cells were significantly increased in the entire subfield. F(3,16)=94.2 for SO, P<0.00001;
F(3,16)=21.8 for SP, P<0.0001; F(3,16)=13.0 for SR, P<0.0005; F(3,16)=5.84 for SLM,
P<0.01, Tukey’s post hoc test, untreated mutant vs mutant at each time point after KA
treatment, ***P<0.0005, **P<0.001, *P<0.05.
(B) Confocal double staining image of Fluoro-Jade B (FJB, green) with GAD67-IR (red) 1
day after KA treatment, showing the degenerating GABAergic neurons in area CA1.
(C) Differential changes in GAD67-IR in area CA1 of fNR1 and the mutant mice 1 day, 7
days and 4 wk after KA treatment compared to their untreated CA1. Inset shows a confocal
higher magnification of the boxed area in CA1, indicating the elevated GAD67-IR
presumably localized to GABAergic neuron axon terminals. In mutant mice, GAD67-IR in
the CA1 cell layer was paradoxically augmented 1 day after treatment (inset), suggesting
massive GABA release, which was not observed in control mice.
(D) Quantification of GAD67-positive cells in the hippocampal subfields for each genotype.
The number of GAD67-positive cells in the mutant CA1 was significantly lower in the fNR1
CA1 1 day, 7 days, and 4 wk after KA treatment; no differences were observed in CA3 or
DG. F(3,32)= 12.2 for genotype × time interaction in CA1, P<0.00005, Tukey’s post hoc
test, †P<0.05 for untreated fNR1 vs fNR1 1 day after KA treatment, ‡P<0.0005 for untreated
mutant vs mutant at each time point after KA treatment, #P<0.0005 for fNR1 vs mutant at
each time point.
(E) Quantification of GAD67-positive cells inside the CA1 subfield for each genotype.
Mutant GAD67-positive cells were severely and permanently decreased in the entire
subfield except SLM, compared to the fNR1 control mice. F(3,32)=10.7 for genotype × time
interaction in SO, P<0.00005; F(3,32)=8.60 for genotype × time interaction in SP, P<0.0005;
F(3,32)=3.24 for genotype × time interaction in SR, P<0.05; F(3,32)=1.56 for genotype × time
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interaction in SLM, P=0.21. Tukey’s post hoc test, untreated mutant vs mutant at each time
point after KA treatment, †P<0.05, ‡P<0.0005; fNR1 vs mutant at each time point, ¶P<0.05,
*P<0.01, §P<0.005, #P<0.0005. Black bar, fNR1 mice; red bar, mutant mice. The number in
parentheses indicates the number of animals for each time point. Stratum oriens (SO),
stratum pyramidale (SP), stratum radiatum (SR), and stratum lacunosum-moleculare (SLM).
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FIG. 8. DTX treatment did not affect mutant SPW-R complex activity
(A) The amplitude (left) and occurrence (middle) of conventional SPW, and the occurrence
(relative value) of ‘giant SPW’ (right) in mutants before (red) and after (blue) DTX
treatment (n=9). (B) The amplitude (left) and the occurrence (right) of mutant ripples before
(red) and after (blue) DTX treatment (n=9). No significant change in SPW-R activity was
observed before and after DTX treatment (Student’s t-test, P=0.09, P=0.61, P=0.88, P=0.68
P=0.73 for SPW amplitude, SPW occurrence, the ratio of giant SPW, ripple amplitude, and
ripple occurrence, respectively). The number in parentheses indicates the number of
animals.
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FIG. 9. Pretreatment with DTX protected CA1 cells from neurodegeneration but failed to
attenuate the severity of epileptic discharges in mutant mice
(A) 3D plots of the maximum behavioral seizure scores (x axis) vs the CA1 damage scores
(y axis) of fNR1 (left, n=8), mutant (middle, n=10) and DTX-pretreated mutant (right, n=9)
mice during 90 min after KA treatment. Z axis shows the number of individual mice. A
subconvulsive dose (0.5 mg/kg) of DTX prevented mutants from KA-induced massive CA1
cell damage. Behavioral seizure severity induced by KA was not affected by DTX.
(B) Quantification of CA1 damage score (middle) in mutant with or without DTX
pretreatment suggests DTX prevented KA-induced excitotoxicity (Student’s t-test,
*P<0.05). No difference was observed in behavioral seizure scores between the genotypes
(left). Right: representative photomicrograph of Neurosilver staining in CA1 from DTX-
pretreated mutants 1 wk after KA treatment, showing no cell death in CA1.
(C) The number (left) and duration (right) of mutant epileptic discharge during 90 min after
KA injection was not affected by DTX pretreatment. DTX-pretreated mutants had a higher
number of epileptic discharges and their longer duration than control mice, but there were no
differences for both measures between DTX-pretreated mutants and mutants without DTX.
Discharge number, Kruskal Wallis test, P<0.005, Mann-Whitney U-test with Bonferroni
correction for multiple comparisons, P<0.05 for controls vs DTX--pretreated mutants, P=1.0
for mutants vs DTX-pretreated mutants; Discharge duration; F(2, 24)=8.86, P<0.005,
Bonferroni post hoc test, P<0.05 for controls vs DTX-pretreated mutants, P=1.0 for mutants
vs DTX-treated mutants. The number in parentheses indicates the number of animals.
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FIG. 10. Pretreatment with DTX restored gamma oscillation and GAD67 activity and
diminished epileptiform activity and CA1 degeneration
(A) Left: a representative spectrogram of KA-induced LFP activity in DTX-pretreated
mutants. DTX injection occurred 90 min before KA injection. Color: log of power spectral
densities. Right: epileptic discharge trace (marked as #1) and a representative trace of 30-50
Hz gamma band oscillatory activity (marked as #2) of DTX-pretreated mutants.
(B) Peak power amplitude of 30-50 Hz gamma band oscillations in the DTX-pretreated
mutants was significantly higher than in mutants without DTX, and was the same level as
control mice, suggesting restored low frequency gamma oscillations by DTX-pretreatment.
F(2,24)=9.98, P<0.001, Bonferroni post hoc test, P=0.32 for controls vs DTX-pretreated
mutants, *P<0.05 for mutants vs DTX-treated mutants.
(C) The representative photomicrographs for GABA-IR of controls (left), mutants (middle),
and mutants with DTX-pretreatment (DTX, right) 20 min after KA treatment. Arrowheads
indicate CA1 cell layers.
(D) An increase in GABA level was observed in CA1 pyramidal cell layer (CA1-pyr) but
not in stratum lucidum in CA3 (CA3-luc) in control animals 20 min after systemic KA i.p.
injection. This KA-induced GABA release was abolished in the mutants, but restored after
pretreatment with DTX. This mutant deficit was observed in the CA1 cell layer, but not in
area CA3. Images were obtained by confocal microscope using ×10 objective. The relative
GABA-IR values were normalized to the level of corpus callosum-IR. Kruskal-Wallis test
followed by post-hoc Mann-Whitney test with Bonferroni’s correction, *P<0.05.
(E) Scatter plot of the peak power amplitude of gamma oscillations vs the number of
epileptiform activity 1 day after KA treatment of fNR1 (filled rhomboid), mutants (open red
circle for Group A mutants, pink circle for Group B mutants) and DTX-pretreated mutants
(blue circle). Each dot represents an individual mouse. DTX diminished the epileptiform
activity and restored low frequency gamma oscillations.
(F) The duration of the mutant epileptiform activity 1 day after KA treatment was
dramatically decreased by DTX pretreatment. F(2,24)=11.7, P<0.0005 for genotype effect,
Jinde et al. Page 30
Eur J Neurosci. Author manuscript; available in PMC 2010 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Bonferroni post hoc test, P=0.15 for control vs DTX-pretreated mutants, *P<0.05 for mutant
vs DTX-pretreated mutants.
(G) Representative photomicrograph of GAD67-IR in DTX-pretreated mutants 1 wk after
KA treatment. Quantitative analysis of GAD67-positive cell in the CA1 subfield showed no
differences between control mice and DTX-pretreated mutants, suggesting DTX
pretreatment fully preserved GABAergic function in the mutant CA1. Black bar, fNR1
mice; red bar, mutant mice. Open red bar, Group A mutant mice; pink bar, Group B mutant
mice. F(2,13)=24.21 for SO, P<0.00005, Bonferroni post hoc test, P=1.0 for controls vs
DTX-pretreated mutants, *P<0.0001 for mutants vs DTX-treated mutants; F(2,13)=25.9 for
SP, P<0.00005, Bonferroni post hoc test, P=0.44 for controls vs DTX-pretreated mutants,
*P<0.00005 for mutants vs DTX-treated mutants; F(2,13)=20.6 for SR, P<0.0001,
Bonferroni post hoc test, P=1.0 for controls vs DTX-pretreated mutants, *P<0.0005 for
mutants vs DTX-treated mutants; F(2,13)=2.17 for SLM, P=15, Bonferroni post hoc test,
P=1.0 for controls vs DTX-pretreated mutants. Stratum oriens (SO), stratum pyramidale
(SP), stratum radiatum (SR), and stratum lacunosum-moleculare (SLM). The number in
parentheses indicates the number of animals. n.s., not significant.
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FIG. 11. KA-induced gamma oscillations and CA1 cell death in CA3-NR1 KO mice
Depiction of how genetic deletion of CA3-NR1 influences CA3-CA1 network activity (blue)
and, upon KA administration, undergoes CA1 neurodegeneration (pink). Post-adolescent
NR1 elimination in CA3 pyramidal cells (GLU cells) diminishes their action potential firing,
thereby reducing the firing of CA1 interneurons (GABA cell) while CA1 pyramidal cell
activity is maintained by reduced feed-forward inhibition. Simultaneously, CA3-NR1
deletion abnormally enhances sharp wave-ripple (SPW-R) activity in CA3. An intermediate
dose of kainic acid (KA, 20 mg/kg, i.p.) facilitates GABA release, thereby eliciting 30-50
Hz gamma oscillations within 20 min, then evoking epileptic discharge-burst activity in the
control animals (black arrow). However, this dose does not extend the epileptic discharges
to the sustained epileptiform activity on the following days, and consequently, no cell death
is observed in the control hippocampus. In contrast, KA-induced GABA release and gamma
oscillations do not occur in area CA1 of the mutants, presumably due to reduced excitability
of CA1 interneurons, and epileptic discharges are instead exacerbated, along with an
enhancement of SPW-R activity (red arrow). A presynaptic GABA release enhancer, DTX
(blue arrow), has no effect on mutant SPW-R activity and seizure severity after KA
administration. Remarkably, however, it assists in KA-induced GABA release which
maintains the integrity of the CA1 GABAergic network, thereby preserving gamma
oscillations, suppressing epileptiform activity, and further protecting mutant CA1 from KA-
induced excitotoxicity. These results suggest that KA-induced GABA release may prevent
epileptic discharges from transforming the sustained epileptiform activity and deteriorating
GAD67-positive cells, which results in no neurodegeneration of CA1 neurons. Overall, the
emergence of KA-induced gamma oscillations predicts good prognosis against KA-induced
hippocampal excitotoxicity in mice. Question mark denotes putative action/change.
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Table 1
Properties of CA3 pyramidal cells in familiar linear tracks
Measurement fNR1 Mutant
Mean firing rate (Hz) 2.38 ± 0.36 0.55 ± 0.09**
Peak firing rate (Hz) 14.5 ± 2.09 7.46 ± 1.31*
Spike width (μS) 542.8 ± 19.4 574.6 ± 20.2
Burst duration (ms) 10.6 ± 0.3 8.9 ± 0.5*
Burst spike frequency (%) 41.9 ± 2.2 33.4 ± 2.5*
20 neurons from 3 fNR1 controls and 25 neurons from 4 mutants. Student’s t-test
*
P<0.05
**
P<0.0005
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